HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[Fluoroquinolones: antimicrobial activity and chemotherapeutic efficacy with respect to various pathogens in highly dangerous diseases].

Abstract
Comparative in vitro and in vivo efficacy of new fluoroquinolones with respect to pathogens of tularemia, glanders, melioidosis and anthrax was estimated. It was shown that the strains of the tularemia, glanders, melioidosis and anthrax pathogens were in vitro highly susceptible to the new agents. The experiments on laboratory animals demonstrated that pefloxacin and sparfloxacin had extremely broad spectra and were of special value in emergency prophylaxis of tularemia, glanders, melioidosis and anthrax.
AuthorsT A Bondareva, V B Kalininskiĭ, I V Borisevich, V P Bondarev, V V Kozhukhov, M Iu Amosov, G V Baramzina, O O Fomenkov, F V Krinitsyn
JournalAntibiotiki i khimioterapii︠a︡ = Antibiotics and chemoterapy [sic] / Ministerstvo meditsinskoĭ i mikrobiologicheskoĭ promyshlennosti SSSR (Antibiot Khimioter) Vol. 52 Issue 11-12 Pg. 21-4 ( 2007) ISSN: 0235-2990 [Print] Russia (Federation)
PMID19275053 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Fluoroquinolones
Topics
  • Animals
  • Anthrax (drug therapy, microbiology)
  • Anti-Bacterial Agents (pharmacology, therapeutic use)
  • Bacillus anthracis (drug effects)
  • Burkholderia pseudomallei (drug effects)
  • Cricetinae
  • Fluoroquinolones (pharmacology, therapeutic use)
  • Francisella tularensis (drug effects)
  • Glanders (drug therapy, microbiology)
  • Guinea Pigs
  • Melioidosis (drug therapy, microbiology)
  • Mesocricetus
  • Tularemia (drug therapy, microbiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: